Journal
CURRENT OPINION IN IMMUNOLOGY
Volume 59, Issue -, Pages 49-56Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2019.03.003
Keywords
-
Categories
Funding
- Wistar Shander Fellowship [61831-33-374]
- NIH IPCAVD [U19 A1109646-04]
- W. W. Smith Charitable Trust [68112-01-383]
Ask authors/readers for more resources
Induction of antigen-specific humoral immunity is a correlate of protection for many diseases and remains a primary vaccine goal. Pathogens can evade such responses by limiting epitope access, by diversifying surface residues, or by keeping antigens in metastable conformations. B cells can target diverse epitopes on an antigen, but only a subset of which produce functional antibodies. Structure-based immunogen engineering can help overcome these hurdles by using structural information for targeted induction of particular antibodies while improving the overall vaccine immunogenicity. This review will cover recent progress in vaccine design, specifically focusing on strategies to stabilize antigens for optimal B-cell epitope exposure, engineer synthetic B-cell epitopes to induce antibodies with specific features and enhancement of vaccine potency through antigen presentation on multivalent particles.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available